Literature DB >> 15055255

Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients.

Kosaku Nitta1, Takashi Akiba, Keiko Uchida, Shigeru Otsubo, Yuriko Otsubo, Takashi Takei, Tetsuya Ogawa, Wako Yumura, Takashi Kabaya, Hiroshi Nihei.   

Abstract

Left ventricular hypertrophy (LVH) is the most frequent cardiac abnormality in patients with end-stage renal disease (ESRD). Recent studies have shown that arterial stiffness is associated with mediacalcinosis in these patients. However, whether arterial stiffness and vascular calcification are associated with the LVH in patients with ESRD has not been well established. Forty-nine patients on chronic hemodialysis participated in this study. 1) To better understand the mechanism underlying the increased incidence of LVH, we studied the relation between LVH and each of arterial wall stiffness, aortic calcification, and numerous clinical parameters in 49 patients on chronic hemodialysis. 2) To evaluate the contribution of arterial stiffness and arterial calcification to LVH in hemodialysis patients, we performed the present clinical analysis on 49 patients on chronic hemodialysis. We used an automatic device to measure arterial pulse wave velocity (PWV) as an index of arterial wall stiffness. The aortic calcification index (ACI) was quantified morphometrically by CT scan. The left ventricular mass index (LVMI) was estimated by M-mode echocardiography. To understand the mechanism underlying the increased incidence of LVH, we examined the factors contributing to LVMI in these patients. The correlation between each of the study parameters and LVMI as an indicator of LVH was then examined. The LVMI value was correlated positively with PWV (r=0.439, p=0.0014), systolic blood pressure (r=0.421, p=0.0023), and ACI (r=0.467, p=0.0006). A stepwise linear regression analysis showed that PWV, systolic blood pressure, and ACI were independently associated with LVH in our subjects. These results suggest that LVH is associated with hypertension, increased arterial stiffness, and the extent of vascular calcification in hemodialysis patients, with vascular calcification being the most important contributor to the development of LVH. Alteration of pulsatile dynamics contributes to an increase in left ventricular load and thus is also related to the LVH in these patients. These results suggest that LVH is associated with hypertension, increased arterial stiffness, and the extent of vascular calcification in hemodialysis patients. Vascular calcification, which alters the pulsatile dynamics and thereby contributes to an increase in left ventricular load, is the most important contributor to the development of LVH in patients undergoing hemodialysis.

Entities:  

Mesh:

Year:  2004        PMID: 15055255     DOI: 10.1291/hypres.27.47

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  46 in total

1.  FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

Authors:  Victoria Shalhoub; Edward M Shatzen; Sabrina C Ward; James Davis; Jennitte Stevens; Vivian Bi; Lisa Renshaw; Nessa Hawkins; Wei Wang; Ching Chen; Mei-Mei Tsai; Russell C Cattley; Thomas J Wronski; Xuechen Xia; Xiaodong Li; Charles Henley; Michael Eschenberg; William G Richards
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

2.  Association of pretransplant serum phosphorus with posttransplant outcomes.

Authors:  Marcelo S Sampaio; Miklos Z Molnar; Csaba P Kovesdy; Rajnish Mehrotra; Istvan Mucsi; John J Sim; Mahesh Krishnan; Allen R Nissenson; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

3.  Arterial haemodynamics on ventricular hypertrophy in rats with simulated aortic stiffness.

Authors:  Hsing I Chen; Nan-Kuang Hsieh; Huai-Ren Chang; Cheng-Tao Hu
Journal:  Pflugers Arch       Date:  2007-09-15       Impact factor: 3.657

4.  Changes in pulse pressure during hemodialysis treatment and survival in maintenance dialysis patients.

Authors:  Paungpaga Lertdumrongluk; Elani Streja; Connie M Rhee; John J Sim; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-01       Impact factor: 8.237

5.  Aortic stiffness in ESRD children before and after renal transplantation.

Authors:  Bilal Aoun; Fleur Lorton; Hala Wannous; Bernard Lévy; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2010-03-30       Impact factor: 3.714

6.  Relation of thoracic aortic distensibility to left ventricular area (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Mouaz H Al-Mallah; Khurram Nasir; Ronit Katz; Joao A Lima; David A Bluemke; Roger S Blumenthal; Songshou Mao; W Gregory Hundley; Matthew J Budoff
Journal:  Am J Cardiol       Date:  2013-10-08       Impact factor: 2.778

7.  Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis.

Authors:  N Al-Hilali; N Hussain; A I Ataia; M Al-Azmi; B Al-Helal; K V Johny
Journal:  Indian J Nephrol       Date:  2009-10

8.  Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.

Authors:  Rajan K Patel; Scott Oliver; Patrick B Mark; Joanna R Powell; Emily P McQuarrie; James P Traynor; Henry J Dargie; Alan G Jardine
Journal:  Clin J Am Soc Nephrol       Date:  2009-09       Impact factor: 8.237

9.  Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients.

Authors:  Mengjing Wang; Haiming Li; Li You; Xiaoling Yu; Min Zhang; Ruijiang Zhu; Chuanming Hao; Zhijie Zhang; Jing Chen
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 10.  Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.

Authors:  Dennis Andress
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.